AbbVie Seeks Early Win Over HHS In Botox Drug Price Suit
By Mark Payne · April 29, 2026, 1:59 PM EDT
When the federal government included Botox in Medicare's drug price negotiation program, which allows Medicare officials to negotiate for lower drug prices, it overstepped its authority, drugmaker AbbVie Inc. told a...
To view the full article, register now.